Barclays Lowers KKR & Co. Inc. (NYSE:KKR) Price Target to $129.00

KKR & Co. Inc. (NYSE:KKR) had its target price cut by analysts at Barclays from $181.00 to $129.00 in a report issued on Friday,Benzinga reports. The firm presently has an “overweight” rating on the asset manager’s stock. Barclays‘s price target indicates a potential upside of 27.22% from the stock’s previous close.

A number of other brokerages have also commented on KKR. Oppenheimer increased their price objective on shares of KKR & Co. Inc. from $153.00 to $175.00 and gave the stock an “outperform” rating in a report on Thursday, December 12th. Citigroup lowered their price objective on shares of KKR & Co. Inc. from $177.00 to $132.00 and set a “buy” rating for the company in a research report on Tuesday, April 8th. Bank of America cut their price objective on shares of KKR & Co. Inc. from $214.00 to $194.00 and set a “buy” rating on the stock in a research report on Friday, April 4th. JMP Securities reduced their price target on KKR & Co. Inc. from $165.00 to $150.00 and set a “market outperform” rating for the company in a research report on Tuesday, April 8th. Finally, Morgan Stanley reduced their price target on KKR & Co. Inc. from $157.00 to $156.00 and set an “equal weight” rating for the company in a research report on Thursday, February 6th. One research analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat, the company has a consensus rating of “Moderate Buy” and an average price target of $151.33.

KKR & Co. Inc. Stock Down 0.5 %

Shares of NYSE:KKR opened at $101.40 on Friday. The company has a debt-to-equity ratio of 0.82, a quick ratio of 0.07 and a current ratio of 0.07. The company has a market capitalization of $90.07 billion, a PE ratio of 30.45, a P/E/G ratio of 1.00 and a beta of 1.77. KKR & Co. Inc. has a 52 week low of $86.15 and a 52 week high of $170.40. The company’s fifty day moving average is $122.22 and its 200-day moving average is $139.51.

Insider Transactions at KKR & Co. Inc.

In related news, major shareholder Genetic Disorder L.P. Kkr sold 6,000,000 shares of the stock in a transaction that occurred on Wednesday, March 5th. The shares were sold at an average price of $32.96, for a total transaction of $197,760,000.00. Following the sale, the insider now owns 19,260,971 shares in the company, valued at approximately $634,841,604.16. This trade represents a 23.75 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Insiders own 39.34% of the company’s stock.

Hedge Funds Weigh In On KKR & Co. Inc.

Institutional investors have recently modified their holdings of the business. McIlrath & Eck LLC acquired a new position in shares of KKR & Co. Inc. during the fourth quarter worth $26,000. Hanson & Doremus Investment Management acquired a new stake in shares of KKR & Co. Inc. during the 4th quarter worth approximately $27,000. Crews Bank & Trust acquired a new stake in shares of KKR & Co. Inc. in the 4th quarter valued at about $30,000. Mascagni Wealth Management Inc. bought a new stake in shares of KKR & Co. Inc. during the fourth quarter valued at approximately $31,000. Finally, Pilgrim Partners Asia Pte Ltd acquired a new position in shares of KKR & Co. Inc. during the fourth quarter worth approximately $34,000. Institutional investors and hedge funds own 76.26% of the company’s stock.

About KKR & Co. Inc.

KKR & Co, Inc operates as an investment firm. It offers alternative asset management as well as capital markets and insurance solutions. The firm’s business segments include Asset Management and Insurance Business. The Asset Management segment engages in providing private equity, real assets, credit and liquid strategies, capital markets, and principal activities.